Therapeutic misconception in clinical research: Frequency and risk factors

IRB Ethics and Human Research

Volumn 26, Issue 2, 2004, Pages 1-8

  Appelbaum, Paul S ^a   Lidz, Charles W ^a   Grisso, Thomas ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; COMPREHENSION; EMPIRICAL APPROACH; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; INTERVIEW; METHODOLOGY; PSYCHOLOGICAL ASPECT; RESEARCH SUBJECT; RISK ASSESSMENT;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

AGE FACTORS; CLINICAL TRIALS; COMPREHENSION; HEALTH STATUS; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; INTERVIEWS; RESEARCH DESIGN; RESEARCH SUBJECTS; RISK ASSESSMENT;

EID: 2342464377     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: 10.2307/3564231     Document Type: Article

References (43)

1. Fried C. Medical Experimentation: Personal Integrity and Social Policy. New York: American Elsevier, 1974, pp. 67-78.
2. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report 1987;17(2):2024.
3. Lidz CW, Appelbaum PS. The therapeutic misconception: Problems and solutions. Medical Care 2002;40(9, suppl.):V-55-V-63.
4. See ref. 3, Lidz and Appelbaum 2002;
5. Dresser R, The ubiquity and utility of the therapeutic misconception. Social Philosophy and Policy 2002;19: 271-294;
6. Hochhauser M. "Therapeutic misconception" and "recruiting doublespeak" in the informed consent process. IRB: Ethics & Human Research 2002;24(1):11-12.
7. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry 1982;5:319-329.
8. Penman DT, Holland JC, Bahna GF, et al. Informed consent for investigational chemotherapy: Patients' and physicians' perceptions. Journal of Clinical Oncology 1984;2:849-855;
9. Schaeffer MH, Krantz DS, Wichman A, et al. The impact of disease severity on the informed consent process in research. American Journal of Medicine 1996;100:261-268;
10. Daugherty CK, Banik DM, Janish L, et al. Quantitative analysis of ethical issues in Phase I Trials: A survey interview study of 144 advanced cancer patients. IRB: Ethics & Human Research 2000;22(3):6-14.
11. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet 2001;358:1772-1777.
12. Featherstone K, Donovan JL. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ 1998;317:1177-1180;
13. Snowden C, Garcia J, Elbourne D. Making sense of randomization: Responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Social Science and Medicine 1997;45:1337-1355;
14. Featherstone K, Donovan JL. "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial. Social Science and Medicine 2002;55:709-719.
15. See ref. 7, Joffe et al. 2001; Advisory Committee on Human Radiation Experiments. Final Report. Washington, DC: U.S. Government Printing Office, 1995, Chap. 16;
16. Cox K. Informed consent and decision-making: Patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Education and Counseling 2002;46:1-38 .
17. See ref. 9, Advisory Committee on Human Radiation Experiments 1995, pp. 747-748.
18. See ref. 9, Advisory Committee on Human Radiation Experiments 1995; National Bioethics Advisory Commission. Research Involving Persons with Mental Disorders that May Affect Decisionmaking Capacity. Volume 1, Report and Recommendations. Rockville, MD: National Bioethics Advisory Commission, 1998;
19. Morin K, Rakatansky H, Riddick FA, et al. Managing conflicts of interest in the conduct of clinical trials. JAMA 2002;287:78-84;
20. Kahn JP, Mastroianni AC. Moving from compliance to conscience: Why we can and should improve on the ethics of clinical research. Archives of Internal Medicine 2001;161:925-928;
21. Wolf LE, Lo B. Ethical issues in clinical research: An issue for all internists. American Journal of Medicine 2000;109:82-85;
22. Miller FG, Rosenstein DL. The therapeutic orientation to clinical trials. NEJM 2003;348:1383-1386;
23. Moreno JD. Abandon all hope? The therapeutic misconception and informed consent. Cancer Investigation 2003;21:481-482.
24. Horng S, Grady C. Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB: Ethics & Human Research 2003;25(1):11-16.
25. See ref. 12, Horng et al. 2003.
26. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
27. Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: Applications to assessment of adaptive behavior. American Journal of Mental Deficiency 1989;86:127-137;
28. Altman DG. Practical Statistics for Medical Research. London, England: Chapman and Hall, 1991, p. 404.
29. See ref. 9, Advisory Committee on Human Radiation Experiments. 1995; ref. 11, National Bioethics Advisory Commission. 1998; ref. 11, Morin et al. 2002; ref. 11, Kahn et al. 2001; ref. 11, Wolf et al. 2000.
30. Sugarman J, McCrory DC, Hubal RC. Getting meaningful informed consent from older adults: A structured literature review of empirical research. Journal of the American Geriatrics Society 1998;46:517-524;
31. Roth LH, Lidz CW, Meisel A, et al. Competency to decide about treatment or research: An overview of some empirical data. International Journal of Law and Psychiatry 1982;5:29-50;
32. Aaronson NK, Visser-Pol E, Leenhouts GHMW, et al. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology 1996;14:984-996;
33. Benson PR, Roth LH, Appelbaum PS, et al. Information disclosure, subject understanding, and informed consent in psychiatric research. Law and Human Behavior 1988;12:455-475.
34. See ref. 9, Advisory Committee on Human Radiation Experiments 1995.
35. See ref. 6, Schaeffer et al. 1996.
36. See ref. 17, Roth et al, 1982; Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology 2001;24:595-607;
37. Simes RJ, Tattersall MHN, Coates AS, et al. Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. British Medical Journal 1986;293:1065-1068;
38. Wirshing DA, Wirshing WC, Marder SR, et al. Informed consent: Assessment of comprehension. American Journal of Psychiatry 1998;155:1508-1511;
39. Carpenter WT, Gold JM, Lahti AC, et al. Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry 2000;57:533-538.
40. See ref. 17, Benson et al. 1988.
41. Davis TC, Holcombe RF, Berkel HG, et al.: Informed consent for clinical trials: A comparative study of standard versus simplified forms. Journal of the National Cancer Institute 1998;90:668-674.
42. Berg J, Appelbaum PS, Lidz CW, et al. Informed Consent: Legal Theory and Clinical Practice, 2nd ed. New York: Oxford University Press, 2001, pp. 291-295.
43. Lavori PW, Sugarman J, Hays MT, et al. Improving informed consent in clinical trials: A duty to experiment. Controlled Clinical Trials 1999;20:187-193.